149 related articles for article (PubMed ID: 4693651)
1. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
Robertson RP; Porte D
J Clin Invest; 1973 Apr; 52(4):870-6. PubMed ID: 4693651
[TBL] [Abstract][Full Text] [Related]
2. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
[TBL] [Abstract][Full Text] [Related]
3. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J
Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
5. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
6. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.
Bagdade JD; Bierman EL; Porte D
J Clin Invest; 1967 Oct; 46(10):1549-57. PubMed ID: 6061732
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
Sive AA; Vinik AI; Levitt N
Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
[TBL] [Abstract][Full Text] [Related]
8. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
9. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
[TBL] [Abstract][Full Text] [Related]
11. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
14. Natural estrous cycle in normal and diabetic bitches in relation to glucose and insulin tests.
Scaramal JD; Renauld A; Gómez NV; Garrido D; Wanke MM; Márquez AG
Medicina (B Aires); 1997; 57(2):169-80. PubMed ID: 9532827
[TBL] [Abstract][Full Text] [Related]
15. Effect of acute selective beta-1-adrenoceptor blockade on hormonal and cardiovascular response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
Kølendorf K; Jensen HA; Holst JJ; Poulsen JE
Scand J Clin Lab Invest; 1982 Feb; 42(1):69-74. PubMed ID: 6127782
[TBL] [Abstract][Full Text] [Related]
16. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.
Robertson RP; Halter JB; Porte D
J Clin Invest; 1976 Mar; 57(3):791-5. PubMed ID: 1249209
[TBL] [Abstract][Full Text] [Related]
17. Insulin responses to glucose and isoproterenol decrease with age.
Watters JM
Can J Surg; 2005 Apr; 48(2):110-6. PubMed ID: 15887790
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of IRI after carbohydrate and aminophylline stimulation in normal, obese and diabetic subjects].
Quartarone M; Cucinotta D; Longo G; Coglitore G; Squadrito G
Minerva Med; 1979 May; 70(22):1629-33. PubMed ID: 450302
[No Abstract] [Full Text] [Related]
19. [Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
Saitta A; Quartarone M; Cucinotta D; Mangano C; Pizzoleo MA; Squadrito G
Minerva Med; 1979 May; 70(22):1611-5. PubMed ID: 36579
[No Abstract] [Full Text] [Related]
20. Portal vein insulin response of glucose intolerant Yucatan miniature swine to common secretogogues.
Spangler RS; Phillips RW
Horm Metab Res; 1982 Sep; 14(9):448-52. PubMed ID: 6754561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
